Zhang, Junjun
Chen, Ming
Yan, Junli
Wang, Chaojun
Deng, Hongdu
Wang, Jiali
Gu, Jiapeng
Wang, Dan
Li, Wenhui
Wang, Chuansheng
Funding for this research was provided by:
Open Project of Psychiatry and Neuroscience Discipline of Second Affiliated Hospital of Xinxiang Medical University (2022-xyefykfkt-003, 2022-xyefykfkt-006)
Xinxiang Science and Technology Bureau (GG2020037, GG2021032)
Open Project of Henan Provincial Clinical Medical Research Centre for Psychiatric and Mental Diseases (2021-zxkfkt-003)
Article History
Received: 13 July 2023
Accepted: 30 November 2023
First Online: 18 December 2023
Declarations
:
: The study protocol was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Xinxiang Medical University (XYEFYLL-Scientific research section-2021-06) on 24/02/2021 and was conducted in accordance with the Declaration of Helsinki and subsequent revisions. That is, all experiments were conducted in accordance with relevant guidelines and regulations. All participants were fully informed of the purpose of the study and signed the informed consent form. Patients were informed that their participation was voluntary, and that they had the right to withdraw from the study at any time with no negative effect on their treatment. The study protocol was also registered at the China Clinical Trial Registry on 26/02/2021 (ExternalRef removed; ChiCTR ID: ChiCTR2100043680).
: Not applicable.
: The authors declare no competing interests.